Skip to main content
. 2019 Jan 15;2019:7429187. doi: 10.1155/2019/7429187

Table 3.

Allele and genotype frequencies of IRF7 SNPs in GD, HT patients, and controls.

SNP Control (%) GD (%) P OR (95% CI) HT (%) P OR (95% CI)
rs1061501
AA 344 (44.7) 281 (47.5) 0.565 142 (47.8) 0.074
AG 357 (46.4) 258 (43.6) 118 (39.7)
GG 69 (9.0) 53 (9.0) 37 (12.5)
A 1045 (67.9) 820 (69.3) 0.436 0.937 (0.796-1.103) 402 (67.7) 0.936 1.008 (0.823-1.235)
G 495 (32.1) 364 (30.7) 192 (32.3)
rs1131665
AA 752 (97.7) 564 (95.3) 0.015 2.074 (1.136-3.787) 285 (96.0) 0.132 1.759 (0.837-3.698)
AG 18 (2.3) 28 (4.7) 12 (4.0)
GG 0 (0) 0 (0) 0 (0)
A 1522 (98.8) 1156 (97.6) 0.016 2.048 (1.127-3.721) 582 (98.0) 0.134 1.743 (0.835-3.642)
G 18 (1.2) 28 (2.4) 12 (2.0)
rs1061502
AA 752 (97.7) 566 (95.6) 0.034 1.919 (1.042-3.535) 285 (96.0) 0.132 1.759 (0.837-3.698)
AG 18 (2.3) 26 (4.4) 12 (4.0)
GG 0 (0) 0 (0) 0 (0)
A 1522 (98.8) 1158 (97.8) 0.035 1.898 (1.036-3.479) 582 (98.0) 0.134 1.743 (0.835-3.642)
G 18 (1.2) 26 (2.2) 12 (2.0)

GD, Graves' disease; HT, Hashimoto's thyroiditis; OR, odds ratio; 95% CI, 95% confidence intervals.